NOVOCAIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Novocain, and when can generic versions of Novocain launch?
Novocain is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in NOVOCAIN is procaine hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NOVOCAIN?
- What are the global sales for NOVOCAIN?
- What is Average Wholesale Price for NOVOCAIN?
Summary for NOVOCAIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Patent Applications: | 3,618 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOVOCAIN at DailyMed |
![NOVOCAIN drug patent expirations Drug patent expirations by year for NOVOCAIN](/p/graph/s/t/NOVOCAIN-patent-expirations.png)
US Patents and Regulatory Information for NOVOCAIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 086797-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |